Abnormalities of ejaculation.
The normal physiologic processes of emission and ejaculation require coordination of neurophysiologic, anatomic, and, in certain cases, psychological phenomena. Disruption of any component, from the embryologic development of the müllerian duct through the medications used for nonrelated systemic disease, can alter the efficient function of ejaculation. Evaluation of the urologic patient who has any of a number of abnormal ejaculatory states requires an understanding of the many possible mechanisms of failure. The majority of these men need evaluation because of a possible male-factor infertile marriage. The potential for improvement is significant, given the development of improved techniques to stimulate ejaculation and the promise shown by extracorporeal fertilization techniques such as in vitro fertilization and gamete intrafallopian tube transfer. These patients deserve complete assessment and optimization of any factors that will enable them to achieve their goal of procreation.
D000293:Adolescent; D000328:Adult; D000818:Animals; D001639:Bicarbonates / Q000627:therapeutic use; D004542:Ejaculation; D005260:Female; D006801:Humans; D007248:Infertility, Male / Q000209:etiology*; D008297:Male; D011247:Pregnancy; D012735:Sexual Dysfunction, Physiological / Q000503:physiopathology / Q000628:therapy; D012964:Sodium / Q000627:therapeutic use; D017693:Sodium Bicarbonate; D013566:Sympathomimetics / Q000627:therapeutic use
D001639:Bicarbonates; D013566:Sympathomimetics; D017693:Sodium Bicarbonate; D012964:Sodium